Singlecare: Can hand sanitizers or hand-washing kill the flu?
Dr. Carl Fichtenbaum says it's what you do with your hands when cleaning them that's important
New research examines what is more effective against the flu: hand sanitizer or hand washing. The study found that when the flu virus is trapped in wet mucus, it can remain infectious for up to four minutes after exposure to hand sanitizer—in other words, much longer than you might have guessed. According to the study, hand-washing—even without soap and even when the infected mucus was wet—was, indeed, very effective in removing the flu virus. It eliminated it in just 30 seconds.
Dr. Carl Fichtenbaum of the Division of Infectious Diseases in the UC College of Medicine, in an interview with Singlecare, said "the fight wasn't fair." He says researchers didn’t study how hand sanitizer works when it’s rubbed into the skin, only when it was dabbed onto fingers, adding "hand rubbing is the critical part of all this."
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.